FDA Drugs recall ·
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL… recall
- Recall number
- D-0249-2026
- Date
- (initiated December 18, 2025)
- Company / brand
- Imprimis NJOF, LLC
1705 Route 46 Ste 6B, Ledgewood, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 778 boxes of 15,540 pre-filled syringes
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Why was it recalled?
Presence of particulate matter - Glass like particles.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
Distribution
U.S Nationwide
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0249-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.